We cannot make a conclusion based on single case reports or small observational studies as to the potential risks of GLP-1 RA therapy in pregnancy, but it is important that these cases are reported in the literature to gather more information to make a conclusion regarding the safety of these medications in pregnancy
6 Insulin also promotes several other cellular processes, in addition to glucose homeostasis, including regulation of glycogen synthesis, lipid metabolism, DNA synthesis, gene transcription, amino acid transport, protein synthesis and degradation 7
doi: 10.2147/tcrm.S160760 94 YamamotoYAokiS
Ultimately, available evidence suggests that the long-term safety profile of GLP-1 receptor agonists remains favorable for most patients who tolerate therapy during the early stages of treatment
Starting in July, Medicare is expected to open the door to obesity drug coverage for seniors, with monthly costs landing somewhere around $50